Trial Details
RECRUITINGBasic Information
| Clinical ID | c540 |
|---|---|
| Identifier | NCT06598943 |
| Trial Title | A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Ulcerative Colitis Chronic |
| Interventions | DRUG: Eltrekibart|DRUG: Mirikizumab|DRUG: Placebo |
Participant Information
| Sponsor | Eli Lilly and Company |
|---|---|
| City | Little Rock |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2024-10-10 |
|---|---|
| Primary Completion Date | 2025-12-27 |
| Completion Date | 2025-09-28 |